The condition of dementia goes through different stages in its development. In order to diagnose the illness and quantify the symptoms of this condition, different rating and diagnosis instruments are used. One of the most common instruments is the Clinical Dementia Rating Scale (CDR). The instrument functions as a numeric device used to quantify the intensity of various dementia symptoms.
The scale was developed on the basis of a clinically structured interview protocol arranged by John C. Morris and other researchers at the Washington School of Medicine. By using this model, a professional health practitioner is able to evaluate a patient's functional as well as cognitive performance in six aspects which are; orientation, judgment, memory, personal care, home and hobbies, problem solving and community affairs.
Cognition tends to be the most prevalent distinguishing factor that is variable from patient to patient in different cases of dementia. The first element of the testing starts with the quality of life that the patient is able to live in without outside intervention.
The Quality of Life test for the determination of the dementia rating scale is to observe the daily actions and behaviors of the patient and figure out just how much the condition is affecting the patient's ability to remember daily routines or memories, and responsibilities. The more the condition affects the patient's cognitive abilities, the higher the rating.
Stage three is a stage where there is also Dementia.There is increased forgetfulness, a slight concentration difficulty, and work performance is decreased. People can get lost regularly and also there is difficulty in finding the words which are right. Normally, there is notice of a Cognitive decline by the person`s loved ones. Average period for this is 7 years before the onset of Dementia.
The Clinical Dementia Rating scale is playing a critical role in pharmacology especially in the production of drugs for halting and arresting the development of dementia related condition such as Alzheimer's disease. CDR scale is important for accurately diagnosing the condition and staging it accurately so as to define appropriate clinical care.
CDR scale is not the only tool in the inquiry domain of dementia. PAINAD scale is another instrument used for assessing the severity of dementia symptoms. This tool is used on patients who have the form of dementia that has escalated to advanced stages so much that the patients can no longer communicate verbally.
The instrument was developed from the Discomfort Scale for Dementia tailored for the Alzheimer type used to quantify pain levels in babies. The scale from which the PAINAD scale was developed is known as the Face, Legs, Cry, Consolability, and Activity scale.
Each case of dementia is unique and this is why it is imperative to determine the unique dementia rating scale of your loved one. This will assist doctors in the measures needed to make sure that your loved one is being taken care of in the most effective ways possible to ensure a happy healthy life.
The scale was developed on the basis of a clinically structured interview protocol arranged by John C. Morris and other researchers at the Washington School of Medicine. By using this model, a professional health practitioner is able to evaluate a patient's functional as well as cognitive performance in six aspects which are; orientation, judgment, memory, personal care, home and hobbies, problem solving and community affairs.
Cognition tends to be the most prevalent distinguishing factor that is variable from patient to patient in different cases of dementia. The first element of the testing starts with the quality of life that the patient is able to live in without outside intervention.
The Quality of Life test for the determination of the dementia rating scale is to observe the daily actions and behaviors of the patient and figure out just how much the condition is affecting the patient's ability to remember daily routines or memories, and responsibilities. The more the condition affects the patient's cognitive abilities, the higher the rating.
Stage three is a stage where there is also Dementia.There is increased forgetfulness, a slight concentration difficulty, and work performance is decreased. People can get lost regularly and also there is difficulty in finding the words which are right. Normally, there is notice of a Cognitive decline by the person`s loved ones. Average period for this is 7 years before the onset of Dementia.
The Clinical Dementia Rating scale is playing a critical role in pharmacology especially in the production of drugs for halting and arresting the development of dementia related condition such as Alzheimer's disease. CDR scale is important for accurately diagnosing the condition and staging it accurately so as to define appropriate clinical care.
CDR scale is not the only tool in the inquiry domain of dementia. PAINAD scale is another instrument used for assessing the severity of dementia symptoms. This tool is used on patients who have the form of dementia that has escalated to advanced stages so much that the patients can no longer communicate verbally.
The instrument was developed from the Discomfort Scale for Dementia tailored for the Alzheimer type used to quantify pain levels in babies. The scale from which the PAINAD scale was developed is known as the Face, Legs, Cry, Consolability, and Activity scale.
Each case of dementia is unique and this is why it is imperative to determine the unique dementia rating scale of your loved one. This will assist doctors in the measures needed to make sure that your loved one is being taken care of in the most effective ways possible to ensure a happy healthy life.
About the Author:
There is a lot of information to learn when it comes to the different stages of dementia. An excellent starting point for Dementia Rating Scale, would be to visit the following website at http://stagesofdementia.org.
No comments:
Post a Comment